Andrew J. Einhorn
CIK 1560685 · Chief Financial Officer · last filed 2025-12-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.55M
Companies
4
Total Filings
11
Lifetime Open-Market Net
$495.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PTHS | Director | 12,000 | $27.50 | $330.0K | $0 | 1 | 2025-12-29 |
| RVL Pharmaceuticals plc (RVLP) Delisted | Chief Financial Officer | 164,325 | $0.03 | $4.6K | $0 | 1 | 2022-01-26 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Chief Financial Officer | 173,932 | $1.11 | $193.1K | $0 | 6 | 2021-11-08 |
| EDGE | Chief Financial Officer | 126,815 | $49.07 | $6.22M | $495.0K | 3 | 2017-03-13 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.